Literature DB >> 15701738

Urinary tract infections: new insights into a common problem.

R Kucheria1, P Dasgupta, S H Sacks, M S Khan, N S Sheerin.   

Abstract

This review discusses recent advances in the understanding of how the common pathogen, uropathogenic Escherichia coli, interacts with the host to lead to infection.

Entities:  

Mesh:

Year:  2005        PMID: 15701738      PMCID: PMC1743204          DOI: 10.1136/pgmj.2004.023036

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  22 in total

1.  Estrogen Replacement Therapy to Prevent Recurrent Urinary Tract Infection in Postmenopausal Women.

Authors:  Jack D. Sobel
Journal:  Curr Infect Dis Rep       Date:  2003-12       Impact factor: 3.725

Review 2.  Defensins: antimicrobial peptides of innate immunity.

Authors:  Tomas Ganz
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

3.  Bacteriuria in families of girls with recurrent bacteriuria. A survey of 112 family members showed similar infections in 14% of the female siblings.

Authors:  R S Fennell; S G Wilson; E H Garin; N D Pryor; C D Sorgen; R D Walker; G A Richard
Journal:  Clin Pediatr (Phila)       Date:  1977-12       Impact factor: 1.168

Review 4.  Epithelial cytokine responses and mucosal cytokine networks.

Authors:  S R Hedges; W W Agace; C Svanborg
Journal:  Trends Microbiol       Date:  1995-07       Impact factor: 17.079

5.  Antibacterial perineal washing for prevention of recurrent urinary tract infections.

Authors:  A S Cass; G W Ireland
Journal:  Urology       Date:  1985-05       Impact factor: 2.649

6.  Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.

Authors:  S Langermann; R Möllby; J E Burlein; S R Palaszynski; C G Auguste; A DeFusco; R Strouse; M A Schenerman; S J Hultgren; J S Pinkner; J Winberg; L Guldevall; M Söderhäll; K Ishikawa; S Normark; S Koenig
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

7.  Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis.

Authors:  P Goluszko; S L Moseley; L D Truong; A Kaul; J R Williford; R Selvarangan; S Nowicki; B Nowicki
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

8.  Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice.

Authors:  L Hagberg; R Hull; S Hull; J R McGhee; S M Michalek; C Svanborg Edén
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

9.  Experimental pyelonephritis in the monkey. VII. Ascending pyelonephritis in the absence of vesicoureteral reflux.

Authors:  J A Roberts; G M Suarez; B Kaack; G Kallenius; S B Svenson
Journal:  J Urol       Date:  1985-06       Impact factor: 7.450

10.  Correlation of P blood group, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis.

Authors:  H Lomberg; L A Hanson; B Jacobsson; U Jodal; H Leffler; C S Edén
Journal:  N Engl J Med       Date:  1983-05-19       Impact factor: 91.245

View more
  51 in total

1.  Epidemiologic Investigation of Extra-intestinal pathogenic E. coli (ExPEC) based on PCR phylogenetic group and fimH single nucleotide polymorphisms (SNPs) in China.

Authors:  Kamal Said Abdallah; Yang Cao; Dian-Jun Wei
Journal:  Int J Mol Epidemiol Genet       Date:  2011-11-25

Review 2.  Lysozymes in the animal kingdom.

Authors:  Lien Callewaert; Chris W Michiels
Journal:  J Biosci       Date:  2010-03       Impact factor: 1.826

3.  Tetracycline resistance in Escherichia coli and persistence in the infantile colonic microbiota.

Authors:  Nahid Karami; Forough Nowrouzian; Ingegerd Adlerberth; Agnes E Wold
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

4.  Implementation of Fourier transform infrared spectroscopy for the rapid typing of uropathogenic Escherichia coli.

Authors:  S E Dawson; T Gibreel; N Nicolaou; H AlRabiah; Y Xu; R Goodacre; M Upton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-08       Impact factor: 3.267

5.  Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.

Authors:  Pascale S Guiton; Corinne K Cusumano; Kimberly A Kline; Karen W Dodson; Zhenfu Han; James W Janetka; Jeffrey P Henderson; Michael G Caparon; Scott J Hultgren
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

6.  Impact of the RNA chaperone Hfq on the fitness and virulence potential of uropathogenic Escherichia coli.

Authors:  Richard R Kulesus; Karen Diaz-Perez; E Susan Slechta; Danelle S Eto; Matthew A Mulvey
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

Review 7.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

8.  Effect of Thymoquinone on Oxidative Stress in Escherichia coli-Induced Pyelonephritis in Rats.

Authors:  Omer Evirgen; Ahmet Gökçe; Oktay Hasan Ozturk; Emel Nacar; Yusuf Onlen; Burcin Ozer; Vicdan Koksaldi Motor
Journal:  Curr Ther Res Clin Exp       Date:  2011-10

9.  Tetracycline-resistant Escherichia coli strains are inherited from parents and persist in the infant's intestines in the absence of selective pressure.

Authors:  Martina Prelog; Katharina Grif; Cornelia Decristoforo; Reinhard Würzner; Ursula Kiechl-Kohlendorfer; Andrea Brunner; Lothar Bernd Zimmerhackl; Dorothea Orth
Journal:  Eur J Pediatr       Date:  2008-12-19       Impact factor: 3.183

10.  (CGG)4-based PCR as a novel tool for discrimination of uropathogenic Escherichia coli strains: comparison with enterobacterial repetitive intergenic consensus-PCR.

Authors:  Wioletta Adamus-Bialek; Arkadiusz Wojtasik; Marta Majchrzak; Marek Sosnowski; Pawel Parniewski
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.